Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 33342-174

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 33342-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 1000s)

505 (Olmesartan Hctz 20 12 5mg 1000s)
macLEODS is a pharmaceutical company that produces tablets containing Olmesartan medoxomil and Hydrochlorothiazide. The tablets are typically prescribed for hypertension. The usual dosage and administration information can be found in the prescribing information. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The tablets are manufactured by Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. The specific quantity of tablets or packaging is not mentioned in the text. The code number provided is DD/DRUGS/DD/375.*
FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 100s)

505 (Olmesartan Hctz 20 12 5mg 100s)
Not available.*
FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 30s)

505 (Olmesartan Hctz 20 12 5mg 30s)
MACLEODS Each tablet contains Olmesartan medoxomil, USP 20 mg and Hydrochlorothiazide, USP 12.5 mg. The tablets are manufactured by Macleods Pharmaceuticals Ltd. and distributed by Macleods Pharma USA, Inc. The usual dosage should be determined based on the Olmesartan Prescribing Information. The tablets should be stored at a temperature of 20 to 25°C (68 to 77°F), with excursions permitted to 15 to 30°C (59 to 86°F). The NDC number for these tablets is 33342-173-07.*
FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 90s)

505 (Olmesartan Hctz 20 12 5mg 90s)
LEOD is a medication that comes in the form of tablets. Each tablet contains 20 mg of Olmesartan medoxomil, USP, and 12.5 mg of Hydrochlorothiazide, USP. The tablets are intended to be stored at a temperature between 20°C (68°F) to 25°C (77°F), with excursions allowed between 15°C (59°F) to 30°C (86°F). The medication is manufactured by Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd. The NDC (National Drug Code) for these tablets is 33342-173-10.*
FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 1000s)

505 (Olmesartan Hctz 40 12 5mg 1000s)
This is the information on a tablet containing Olmesartan medoxomil and Hydrochlorothiazide. Each tablet contains 40 mg of Olmesartan medoxomil and 12.5 mg of Hydrochlorothiazide. The usual dosage should be determined based on the prescribing information for dosage and administration. The tablets should be stored at a temperature between 20°C and 25°C (68°F and 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The tablets are manufactured by Macleods Pharmaceuticals Ltd in Daman, India and distributed by Macleods Pharma USA, Inc.*
FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 100s)

FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 30s)

FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 90s)

FDA Label Image

505 (Olmesartan Hctz 40 25mg 1000s)

505 (Olmesartan Hctz 40 25mg 1000s)
Each tablet contains Olmesartan medoxomil, USP 40 mg and Hydrochlorothiazide, USP 25 mg. The usual dosage for Olmesartan medoxomil can be found in the prescribing information. Store the tablets at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd in Princeton, NJ, 08540 and Daman (India) respectively. This information is for a pack of 1000 tablets.*
FDA Label Image

505 (Olmesartan Hctz 40 25mg 100s)

505 (Olmesartan Hctz 40 25mg 100s)
Pharma USA is the manufacturer of Olmesartan Medoxomil and Hydrochlorothiazide Tablets, which contain 40 mg of Olmesartan Medoxomil and 25 mg of Hydrochlorothiazide. This package contains 100 tablets in unit dose packaging. The tablets should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The usual dosage and administration should be followed as specified in the Prescribing Information. This package is not child-resistant, so a child-resistant container should be used if the tablets are dispensed for outpatient use.*
FDA Label Image

505 (Olmesartan Hctz 40 25mg 30s)

FDA Label Image

505 (Olmesartan Hctz 40 25mg 90s)

505 (Olmesartan Hctz 40 25mg 90s)
This is a description of a medication containing Olmesartan medoxomil and Hydrochlorothiazide. Each tablet contains 40 mg of Olmesartan medoxomil and 25 mg of Hydrochlorothiazide. The usual dosage and other important information can be found in the prescribing information. The tablets need to be stored at a temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions to 15°C to 30°C (59°F to 86°F). This medication is manufactured by Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd. The code number is DD/DRUGS/DD/375. There are 90 tablets in each bottle. The address of Macleods Pharma USA, Inc. is in Princeton, NJ 08540 and the address of Macleods Pharmaceuticals Ltd. is in Daman, INDIA.*
FDA Label Image

505 (Olmesartan Hctz Structure)

FDA Label Image

505 (Olmesartan Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.